Science Explorer Back to mapMap
Hospital / health system · Grand Rapids · United States

Infusion Associates

Research works
11
▲ 185% vs 2018-21
Citations
138
13.1 per fractional work
Top-10% rate
8.2%
all institutions 10.0%
Open access
28%
world 40%
International
31%
world 18%

Not ranked overall: Infusion Associates is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Infusion Associates work in?

In all years, 59% of research at Infusion Associates is in Health Sciences, 16% in Life Sciences. Its largest fields are Medicine (55%), Immunology and Microbiology (11%), Engineering (6%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 59.2% of its workMedicine: 6 fractional works · 54.9% of its workPhysiology: 1 fractional works · 13.1% of its workSurgery: 1 fractional works · 8.6% of its workPsychiatry and Mental health: 0 fractional works · 4.2% of its workPulmonary and Respiratory Medicine: 0 fractional works · 4.2% of its workEpidemiology: 0 fractional works · 3.1% of its workInfectious Diseases: 0 fractional works · 3.1% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 2.9% of its workOncology: 0 fractional works · 2.4% of its workHematology: 0 fractional works · 2.1% of its workDermatology: 0 fractional works · 1.7% of its workNephrology: 0 fractional works · 1.6% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 1.0% of its workPathology and Forensic Medicine: 0 fractional works · 1.0% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 1.0% of its workGastroenterology: 0 fractional works · 1.0% of its workRheumatology: 0 fractional works · 0.9% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.8% of its workAnatomy: 0 fractional works · 0.7% of its workEmergency Medicine: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.5% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 3.4% of its workSpeech and Hearing: 0 fractional works · 1.6% of its workEmergency Medical Services: 0 fractional works · 1.0% of its workGeneral Health Professions: 0 fractional works · 0.8% of its workNursing: 0 fractional works · 0.9% of its workIssues, ethics and legal aspects: 0 fractional works · 0.5% of its workNutrition and Dietetics: 0 fractional works · 0.4% of its workLife Sciences: 2 fractional works · 16.0% of its workImmunology and Microbiology: 1 fractional works · 10.6% of its workImmunology: 1 fractional works · 10.6% of its workBiochemistry, Genetics and Molecular Biology: 0 fractional works · 4.6% of its workMolecular Biology: 0 fractional works · 2.5% of its workGenetics: 0 fractional works · 1.6% of its workBiotechnology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 0 fractional works · 0.4% of its workNeuroscience: 0 fractional works · 0.4% of its workDevelopmental Neuroscience: 0 fractional works · 0.4% of its workPhysical Sciences: 1 fractional works · 12.8% of its workEngineering: 1 fractional works · 5.5% of its workElectrical and Electronic Engineering: 0 fractional works · 3.1% of its workBiomedical Engineering: 0 fractional works · 2.4% of its workComputer Science: 0 fractional works · 4.8% of its workArtificial Intelligence: 0 fractional works · 3.1% of its workComputer Networks and Communications: 0 fractional works · 1.6% of its workChemistry: 0 fractional works · 2.6% of its workOrganic Chemistry: 0 fractional works · 2.6% of its workSocial Sciences: 1 fractional works · 12.0% of its workEconomics, Econometrics and Finance: 0 fractional works · 3.7% of its workEconomics and Econometrics: 0 fractional works · 3.7% of its workSocial Sciences: 0 fractional works · 3.3% of its workSociology and Political Science: 0 fractional works · 2.4% of its workEducation: 0 fractional works · 1.0% of its workDecision Sciences: 0 fractional works · 3.1% of its workInformation Systems and Management: 0 fractional works · 3.1% of its workPsychology: 0 fractional works · 1.0% of its workClinical Psychology: 0 fractional works · 1.0% of its workBusiness, Management and Accounting: 0 fractional works · 0.8% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.8% of its workALL ITS WORKInfusionAssociates11fractional works, all years
Life Sciences16%Physical Sciences13%Health Sciences59%Social Sciences12%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Medicine654.9%
    2. Health Professions03.4%
    3. Nursing00.9%
    1. Immunology and Microbiology110.6%
    2. Biochemistry, Genetics and Molecular Biology04.6%
    3. Agricultural and Biological Sciences00.4%
    4. Neuroscience00.4%
    1. Engineering15.5%
    2. Computer Science04.8%
    3. Chemistry02.6%
    1. Economics, Econometrics and Finance03.7%
    2. Social Sciences03.3%
    3. Decision Sciences03.1%
    4. Psychology01.0%
    5. Business, Management and Accounting00.8%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 1.29× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 2.02× its world share, 0 worksImmunology and Micro…Chemistry: 1.17× its world share, 0 worksChemistryComputer Science: 1.30× its world share, 0 worksComputer ScienceEngineering: 0.51× its world share, 0 worksEngineeringHealth Professions: 0.96× its world share, 0 worksHealth ProfessionsMedicine: 2.33× its world share, 2 worksMedicineBusiness, Management and Accounting: 0.79× its world share, 0 worksBusiness, Management…Decision Sciences: 10.50× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 4.74× its world share, 0 worksEconomics, Econometr…Psychology: 0.48× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Decision Sciences, 10.5×. Every wedge is a field page.

All 11 fields, with their numbers
  1. Decision Sciences10.50×0 works
  2. Economics, Econometrics and Finance4.74×0 works
  3. Medicine2.33×2 works
  4. Immunology and Microbiology2.02×0 works
  5. Computer Science1.30×0 works
  6. Biochemistry, Genetics and Molecular Biology1.29×0 works
  7. Chemistry1.17×0 works
  8. Health Professions0.96×0 works
  9. Business, Management and Accounting0.79×0 works
  10. Engineering0.51×0 works
  11. Psychology0.48×0 works

Who are the top researchers at Infusion Associates?

Ranked on the quality score, Khan J. Nedd lead among researchers whose main affiliation is Infusion Associates.

  1. 1 Khan J. Nedd United States · #1,477,468 worldwide 1.2k citations · 22 works
All ranked researchers at Infusion Associates

What are the most cited papers from Infusion Associates?

The most cited paper from Infusion Associates is "Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat" (Dominique Paul Germain et al., 2016), with 566 citations. Next come "Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study" (395) and "Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study" (81).

Most cited papers
#PaperReleasedCitations
1 Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat Dominique Paul Germain et al. · New England Journal of Medicine Open access 10 Aug 2016 566
2 Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study Derralynn A. Hughes et al. · Journal of Medical Genetics Open access 10 Nov 2016 395
3 Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT study Ulla Feldt‐Rasmussen, Derralynn A. Hughes, Gere Sunder–Plassmann et al. · Molecular Genetics and Metabolism Open access 15 Aug 2020 81
4 Safety and efficacy of alternative alglucosidase alfa regimens in Pompe disease Laura E. Case, Carl Bjartmar, Claire L Morgan et al. · Neuromuscular Disorders Open access 20 Dec 2014 59
5 Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study Eric L Wallace et al. · Journal of Medical Genetics Open access 8 Nov 2023 49
All 29 most cited papers, with filters and sorting

Which research topics does Infusion Associates publish most on?

By volume in 2022-now: Lysosomal Storage Disorders Research, Data Analysis with R, Scientific Computing and Data Management and Intravenous Infusion Technology and Safety.

  1. 1 Lysosomal Storage Disorders Research Physiology 0 works
  2. 2 Data Analysis with R Artificial Intelligence 0 works
  3. 3 Scientific Computing and Data Management Information Systems and Management 0 works
  4. 4 Intravenous Infusion Technology and Safety Biomedical Engineering 0 works
  5. 5 Diverse Scientific and Economic Studies Economics and Econometrics 0 works
  6. 6 Inflammatory Bowel Disease Genetics 0 works
  7. 7 HIV/AIDS drug development and treatment Infectious Diseases 0 works
  8. 8 Neurological and metabolic disorders Endocrinology, Diabetes and Metabolism 0 works
  9. 9 Interprofessional Education and Collaboration General Health Professions 0 works
  10. 10 Healthcare Systems and Technology Organizational Behavior and Human Resource Management 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available28.5%not open71.5%

World: 40% of research is openly available.

with international co-authors31.1%domestic only68.9%

World: 18% is written across borders.

How has Infusion Associates's research output changed?

Output in 2022-2025 was 185% higher than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Infusion Associates as a percentage of every work published that year, 0.000014% in 2024.

still counting0.000050%0.00010%Infusion Associates0.000025% in 2025200020102020

Fractional works of Infusion Associates over all fractional works that year. How the balance of science has shifted.

Other research institutions in Grand Rapids

All research institutions in Grand Rapids

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Infusion Associates. Posts are plain text and can be reported.